作者:董寧寧
2017-11-09 16:13來源:中國證券報·中證網
中(zhong)證(zheng)網訊(xun) 北陸藥業(300016)11月9日(ri)晚間公(gong)告,近日(ri),公(gong)司獲得兩份(fen)中(zhong)華人民共和國國家知識產權(quan)局頒發的發明專(zhuan)利證(zheng)書。分(fen)別為:一(yi)種氫溴酸沃(wo)(wo)替西汀(ting)一(yi)仲丁醇合物(wu)及其制備方法、一(yi)種氫溴酸沃(wo)(wo)替西汀(ting)a晶型的制備方法。
兩項發明專利是公司在新(xin)型抗抑(yi)郁(yu)藥物氫溴(xiu)酸(suan)沃(wo)替西汀的合成工(gong)藝探(tan)索(suo)過(guo)程中形(xing)成的知(zhi)識(shi)產權。
中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網聲(sheng)明:凡本(ben)(ben)網注(zhu)明“來(lai)源:中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)證(zheng)(zheng)券報(bao)(bao)·中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網”的(de)(de)(de)所有作品,版權均屬于中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)證(zheng)(zheng)券報(bao)(bao)、中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網。中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)證(zheng)(zheng)券報(bao)(bao)·中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網與作品作者聯合聲(sheng)明,任何(he)組織未經中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)證(zheng)(zheng)券報(bao)(bao)、中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網以(yi)及作者書面授權不得(de)轉載、摘編或利用其(qi)它(ta)(ta)方式使用上述作品。凡本(ben)(ben)網注(zhu)明來(lai)源非中(zhong)(zhong)(zhong)(zhong)(zhong)國(guo)(guo)(guo)證(zheng)(zheng)券報(bao)(bao)·中(zhong)(zhong)(zhong)(zhong)(zhong)證(zheng)(zheng)網的(de)(de)(de)作品,均轉載自其(qi)它(ta)(ta)媒體,轉載目的(de)(de)(de)在(zai)于更好(hao)服務讀者、傳遞信息之需,并不代表本(ben)(ben)網贊同(tong)其(qi)觀點,本(ben)(ben)網亦不對其(qi)真(zhen)實性負責,持異議者應與原(yuan)出處單位(wei)主張權利。
2016年度“金牛理財產品”頒獎典...
第二十一屆(2017年度)中國資本...
中水集團遠洋股份有限公司投資者...
特別鏈接:政府部門交易機構證券期貨四所兩司新聞發布平臺友情鏈接版權聲明 關于報社關于本站廣告發布免責條款
中國證券報社版權所有,未經書面授權不得復制或建立鏡像 經營許可證編號:京B2-20180749 京公網安備0-1 Copyright 2001-2018 China Securities Journal. All Rights Reserved
中國(guo)證(zheng)券(quan)報社版權(quan)(quan)所有,未經書面授權(quan)(quan)不得復制(zhi)或(huo)建立(li)鏡像
經營(ying)許可證編號:京(jing)B2-20180749 京(jing)公(gong)網安(an)備(bei)0-1
Copyright 2001-2018 China Securities Journal. All Rights Reserved